公开(公告)号：EP1948146A2

公开(公告)日：2008-07-30

申请号：EP06805783.5

申请日：2006-09-20

申请人： Revotar Biopharmaceuticals AG

发明人： AYDT, Ewald ,  KRANICH, Remo ,  BUSEMANN, Anke

IPC分类号： A61K31/05 ,  A61P11/00

CPC分类号： A61K31/05

摘要： Pharmaceutical compositions comprising at least one compound of the formulas (Ia) or (Ib) or (IIa) or (IIb) and a pharmaceutically acceptable carrier wherein the symbols and substituents have the following meaning -X- is e.g. and Y being e.g. or the pharmaceutically acceptable salts can be applied to modulate the in- vitro and in- vivo binding processes mediated by E-, P- or L-selectin binding.

公开(公告)号：EP1940372B1

公开(公告)日：2011-11-09

申请号：EP06792185.8

申请日：2006-09-20

申请人： Revotar Biopharmaceuticals AG

发明人： AYDT, Ewald ,  KRANICH, Remo ,  BUSEMANN, Anke

IPC分类号： A61K31/05 ,  A61P11/00

CPC分类号： A61K31/05

摘要： Pharmaceutical compositions comprising at least one compound of the formulas (Ia) or (Ib) and a pharmaceutically acceptable carrier wherein the symbols have the following meaning -X- is e.g. and Y being e.g. or the pharmaceutically acceptable salts can be applied to modulate the in-vitro and in-vivo binding processes mediated by E-, P- or L-selectin binding.

公开(公告)号：EP1948146B1

公开(公告)日：2012-11-07

申请号：EP06805783.5

申请日：2006-09-20

申请人： Revotar Biopharmaceuticals AG

发明人： AYDT, Ewald ,  KRANICH, Remo ,  BUSEMANN, Anke

IPC分类号： A61K31/05 ,  A61P11/00

CPC分类号： A61K31/05

公开(公告)号：EP1940372A1

公开(公告)日：2008-07-09

申请号：EP06792185.8

申请日：2006-09-20

申请人： Revotar Biopharmaceuticals AG

发明人： AYDT, Ewald ,  KRANICH, Remo ,  BUSEMANN, Anke

IPC分类号： A61K31/05 ,  A61P11/00

CPC分类号： A61K31/05

摘要： Pharmaceutical compositions comprising at least one compound of the formulas (Ia) or (Ib) and a pharmaceutically acceptable carrier wherein the symbols have the following meaning -X- is e.g. and Y being e.g. or the pharmaceutically acceptable salts can be applied to modulate the in-vitro and in-vivo binding processes mediated by E-, P- or L-selectin binding.

公开(公告)号：EP1937238A1

公开(公告)日：2008-07-02

申请号：EP06805784.3

申请日：2006-09-20

申请人： Revotar Biopharmaceuticals AG

发明人： AYDT, Ewald ,  KRANICH, Remo

IPC分类号： A61K31/167 ,  A61K31/191 ,  A61K31/341 ,  A61K31/381 ,  A61K31/4418 ,  A61K31/4436 ,  A61K31/505 ,  A61K31/5377 ,  A61P1/00 ,  A61P11/00 ,  A61P17/00 ,  A61P17/06 ,  A61P29/00 ,  A61P43/00 ,  C07D213/30

CPC分类号： C07D213/30 ,  A61K31/167 ,  A61K31/191 ,  A61K31/341 ,  A61K31/381 ,  A61K31/4418 ,  A61K31/4436 ,  A61K31/505 ,  A61K31/5377 ,  C07C235/34 ,  C07C235/38 ,  C07D213/40 ,  C07D213/75 ,  C07D239/20 ,  C07D307/68 ,  C07D333/24 ,  C07D409/04 ,  C07D409/12

摘要： Pharmaceutical compositions comprising at least one compound of e.g. the formulas (Ie) and a pharmaceutically acceptable carrier which is useful in a medicine wherein the symbols and substituents have the following meaning -X- is e.g. and Y is e.g. or the pharmaceutically acceptable salts, esters or amides and prodrugs of the above identified compounds can be applied to modulate the in- vitro and in- vivo binding processes mediated by E-, P- or L-selectin binding.

公开(公告)号：EP1937237A1

公开(公告)日：2008-07-02

申请号：EP06792184.1

申请日：2006-09-20

申请人： Revotar Biopharmaceuticals AG

发明人： AYDT, Ewald ,  KRANICH, Remo

IPC分类号： A61K31/167 ,  A61K31/191 ,  A61K31/341 ,  A61K31/381 ,  A61K31/4418 ,  A61K31/4436 ,  A61K31/505 ,  A61K31/5377 ,  C07D213/30 ,  C07D213/40 ,  C07D213/75 ,  C07D239/20 ,  C07D307/68 ,  C07D333/24 ,  C07D409/04

CPC分类号： C07C235/38 ,  C07D213/30 ,  C07D213/40 ,  C07D213/75

摘要： Pharmaceutical compositions comprising at least one compound of the formula (I) and a pharmaceutically acceptable carrier which is useful in a medicine wherein the symbols and substituents have the following meaning -X- is e.g. and Y being e.g. or the pharmaceutically acceptable salts, esters or amides and prodrugs can be applied to modulate the in-vitro and in-vivo binding processes mediated by E-, P- or L-selectin binding.